X4 Pharmaceuticals, Inc. Stock
Price
Target price
€0.96
€0.96
0.590%
0.006
0.590%
€2.78
08.05.24 / Tradegate
WKN: A2PFVY / Symbol: XFOR / Name: X4 Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
X4 Pharmaceuticals, Inc. Stock
The X4 Pharmaceuticals, Inc. stock is trending slightly upwards today, with an increase of €0.006 (0.590%) compared to yesterday's price.
With 6 Buy predictions and not the single Sell prediction the community is currently very high on X4 Pharmaceuticals, Inc..
With a target price of 2 € there is potential for a 107.58% increase which would mean more than doubling the current price of 0.96 € for X4 Pharmaceuticals, Inc..
So far the community has only identified positive things for X4 Pharmaceuticals, Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of X4 Pharmaceuticals, Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of X4 Pharmaceuticals, Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. | 0.590% | -8.673% | -19.237% | -34.899% | 23.526% | - | - |
| Ardelyx Inc. | 0.050% | 31.475% | 16.607% | 106.772% | 36.298% | 41.946% | - |
| Evolus Inc | 0.830% | 12.150% | -0.826% | 52.866% | 32.597% | 63.265% | - |
| Salarius Pharmaceuticals Inc. | -0.980% | -0.971% | -0.971% | -77.826% | -26.486% | -98.326% | -99.993% |
Comments
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target raised by analysts at HC Wainwright from $3.00 to $5.00. They now have a "buy" rating on the stock.
Show more
Ratings data for XFOR provided by MarketBeat
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Show more
Ratings data for XFOR provided by MarketBeat
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Show more
Ratings data for XFOR provided by MarketBeat
